FGF10 mitigates doxorubicin-induced myocardial toxicity in mice via activation of FGFR2b/PHLDA1/AKT axis.
Zhou DP, Deng LC, Feng X, Xu HJ, Tian Y, Yang WW, Zeng PP, Zou LH, Yan XH, Zhu XY, Shu DH, Guo Q, Huang XY, Bellusci S, Lou Z, Li XK, Zhang JS.
Zhou DP, et al.
Acta Pharmacol Sin. 2023 Oct;44(10):2004-2018. doi: 10.1038/s41401-023-01101-x. Epub 2023 May 24.
Acta Pharmacol Sin. 2023.
PMID: 37225844
Free PMC article.